久久亚洲国产成人影院-久久亚洲国产的中文-久久亚洲国产高清-久久亚洲国产精品-亚洲图片偷拍自拍-亚洲图色视频

Global EditionASIA 中文雙語Fran?ais
World
Home / World / Americas

Inovio says COVID-19 vaccine produces antibodies in mice, guinea pigs

Updated: 2020-05-21 10:05
Share
Share - WeChat
FILE PHOTO: Small bottles labeled with a "Vaccine COVID-19" sticker and a medical syringe are seen in this illustration taken taken April 10, 2020. [Photo/Agencies]

US immunotherapy company Inovio Pharmaceuticals Inc said on Wednesday its experimental vaccine to prevent coronavirus infection produced protective antibodies and immune system responses in mice and guinea pigs.

The company's shares, which have more than quadrupled this year on hopes of its vaccine working, surged another 18% to $15.77 early trading.

"We saw antibody responses that do many of the things we would want to see in an eventual vaccine," said Dr. David Weiner, director of the vaccine and immunotherapy center at the Wistar Institute, which has collaborated with Inovio. "We are able to target things that would prevent the virus from having a safe harbor in the body."

There are currently no approved treatments or vaccines for COVID-19, the disease caused by the new coronavirus, with governments, drugmakers and researchers working on around 100 vaccine programs. Experts predict a safe and effective vaccine could take 12 to 18 months to develop.

Inovio began human testing of its vaccine in April. Many other drugmakers including Moderna Inc, Pfizer Inc , Johnson & Johnson, Sanofi and AstraZeneca Plc are also in various stages of vaccine development.

On Monday, Moderna said its experimental COVID-19 vaccine produced protective antibodies in a small group of healthy volunteers, according to very early data, putting it at the front in the race.

Inovio said preliminary results from its human trial are expected in June. The 40 healthy participants in the Phase 1 trial are given two shots, four weeks apart, of the vaccine, called INO-4800, and then followed for two weeks.

"We are already seeing safety data and it has been benign," Dr. Katherine Broderick, head of research and development at Inovio, told Reuters. "Some people have slight redness of the arm."

Both Moderna and Inovio are using newer technology that focuses on specific genes on the outer "spike" portion of the virus.

Inovio's vaccine was designed using its DNA medicine platform, while Moderna's vaccine uses messenger RNA (mRNA) technology. Both companies have no approved drug in the market.

Reuters

 

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 精品精品国产欧美在线观看 | 亚洲国产成人在人网站天堂 | 国产一区二区久久精品 | 久久视频免费在线观看 | 91国内精品久久久久免费影院 | 美女做爰视频在线观看免费 | 免费特黄一级欧美大片 | 看一级毛片 | 久久精品久久精品久久精品 | 色天天躁夜夜躁天干天干 | 久久不色| 欧美色视频在线观看 | 国产午夜精品理论片 | 亚洲国产精品看片在线观看 | 欧美性视频一区二区三区 | 国产草草影院ccyycom软件 | 国产三级毛片 | 大香伊蕉国产短视频69 | 中文字幕乱码中文乱码综合 | 老鸭窝 国产 精品 91 | 欧美在线成人午夜网站 | 理论片亚洲 | 九九香蕉 | 日韩亚洲国产综合久久久 | 欧美成人免费高清二区三区 | 在线亚洲综合 | 久草中文网 | 欧美亚洲一级片 | 免费a级毛片视频 | 99久久国语露脸精品对白 | 窝窝女人体国产午夜视频 | 农村寡妇女人一级毛片 | 波多野结衣在线视频免费观看 | 日韩毛片免费线上观看 | 精品国产高清久久久久久小说 | 波多野结衣在线观看一区二区 | 国产福利片在线 易阳 | 美女一级视频 | 欧美最新的精品videoss | 国产精选莉莉私人影院 | 日本人的色道www免费一区 |